Heinz‐Josef Lenz
- CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy
2017/11/26 by Ryuma Tokunaga, Wu Zhang, Madiha Naseem +8 · 15 citations
Medicine · Immunology and Microbiology · #Chemokine receptors and signaling #Immunotherapy and Immune Responses #Cancer Immunotherapy and Biomarkers
- Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer
2017/06/20 by Alan P. Venook, Donna Niedzwiecki, Heinz‐Josef Lenz +29 · 3 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer Genomics and Diagnostics #Colorectal Cancer Surgical Treatments #Colorectal Cancer Treatments and Studies
- The current state of molecular testing in the treatment of patients with solid tumors, 2019
2019/05/22 by Wafik S. El‐Deiry, Richard M. Goldberg, Heinz‐Josef Lenz +11 · 26 citations
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer Genomics and Diagnostics #Cancer Research and Treatments #Lung Cancer Treatments and Mutations
- Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
2024/11/27 by Thierry André, Elena Élez, Eric Van Cutsem +24 · 1 voice · 2 citations
Medicine · #Cancer Immunotherapy and Biomarkers #Genetic factors in colorectal cancer #Colorectal Cancer Treatments and Studies